Did You Know?

Editor’s Picks

Latest News

Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial

Awakn intends to run a Phase III trial for 'Ketamine-Assisted Psychotherapy for Alcohol Use Disorder'London, United Kingdom--(Newsfile Corp. - March...

Strong Start to 2021: Glocal Healthcare Team Signs Contracts in Namibia and Uzbekistan and is Recognized by Her Majesty, Queen Mathilde of Belgium as Leading, International Healthcare Innovator

KOLKATA, India & DELRAY BEACH, Fla.--(BUSINESS WIRE)--Glocal Healthcare Systems (“Glocal” or the “Company”), a global industry-leading provider of digitally enabled...

error: Content is protected !!